Company announcements · 13. 11. 2026.1 min read

Leqembi® Pen subcutaneous treatment launched in Japan

Локални аутоматски превод · Изворни језик извора

Illustration generated by Business News; it is not a source photograph.

Сажетак

STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…

Изворни језик извора: PR Newswire UK — News ReleasesПрочитајте оригинал →